Abbott has recently received the US Food and Drug Administration nod to use its DBS device for treatment-resistant depression
Better serving global partners and advancing healthcare innovation
Merck’s first microbiology application and training lab in India
Allegra-D had U.S. retail sales of approximately $45 million as of May 2022 according to IRI.
DS-7300 is a specifically designed potential first-in-class B7-H3 directed antibody drug conjugate
The Elecsys Amyloid Plasma Panel has the potential to ensure better identification of patients that require further confirmatory testing, supporting a more timely and accessible diagnosis.
The partnership will accelerate stockpiling, channel distribution and hospital access for the amubarvimab/romlusevimab combination in China
ABDM Hackathon Round 1 – Kickstarting Unified Health Interface (UHI) is being held from 14th to 17th July 2022 as a hybrid event
The approval has been accorded by IFCI Limited for manufacturing of the product "7 ACA"
ExoBrite antibody conjugates are validated and optimized for bright and specific detection of exosome markers
Subscribe To Our Newsletter & Stay Updated
